Jyong Bio (MENS): Market Cap to Sales Volume

Corporate company logo of Jyong Biotech Limited (MENS)

A critical liquidity shortage and dependence on loans predetermine a negative trend, as confirmed by the P/S levels on the Jyong Biotech Ltd (MENS) chart available on GURU.Markets, where the current metric equals . Trade wars between Beijing and Washington further complicate the situation by creating export barriers. Additionally, the global market fragmentation disrupts raw material supply chains and hinders the conduct of international clinical trials.

MENS Jyong Biotech Corp Price-to-Revenue Ratio (07/04/2022 - 11/15/2026)

Analytical breakdowns for Jyong Bio (MENS)

- share price and consensus valuation forecast:
Price Performance Chart Jyong Biotech Limited|MENS - Price Target Chart
- stock exchange capitalization data:
Market Value Jyong Biotech Ltd|MENS - Real Price to Acquire Entire Company
- book capitalization information:
Net Asset Value per Share Jyong Biotech|MENS - Company Book Value|Market-to-Book Ratio jyongbio.com|MENS - Aggregate Company Assets
- business debt structure and liquidity details:
Debt to Equity Ratio Jyong Biotech Ltd|MENS - Long-Term Debt to Capital|Short-Term Indebtedness to Equity Jyong Biotech|MENS - Company Total Debt|Debt to Net Assets Ratio Jyong Bio|MENS - Company Long-Term Debts|Company Short-Term Debt Jyong Biotech|Interim Coverage Ratio jyongbio.com
- earnings and multiples data:
MENS - Company Net Income|Expected Net Profit Jyong Biotech Ltd|MENS - Price to Earnings Ratio|Market Cap to Future Earnings Ratio Jyong Biotech Corp|MENS - PEG Multiple|Company Value to EBITDA Jyong Bio|MENS - Operating profit EBITDA|Net earnings per share for the last 12 months Jyong Biotech|MENS - Net earnings per share (EPS TTM)|Year-over-year earnings per one share growth for the last 12 months jyongbio.com|MENS - Net earnings per share growth this year|Expected earnings per share trend next year Jyong Biotech Ltd
- total revenue and sales volume data:
MENS - Company Revenue|Company Projected Revenue Jyong Biotech Corp|MENS - Market Cap to Revenue|Price to Expected Revenue Ratio Jyong Bio|MENS - Sales Growth YoY (TTM)
Summary company analytics:Jyong Biotech, MENS
Manufactured products of Jyong Biotech Corp

The P/S multiple compares the market capitalization of Jyong Biotech Ltd (MENS) to its revenue, allowing for the valuation of each unit of sales within fundamental analysis. The stability of biopharmaceutical supply chains minimizes operational risks; therefore, the P/S multiple trend serves as an accurate indicator of market confidence in the efficiency of this logistics model and the justification of the current business valuation.

Competing companies

HLN (Haleon) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Kenvue Inc KVUE|Verona Pharma Corp - Price-to-Revenue Ratio|ligand.com - P/S Multiple|amneal.com (AMRX) - Market Cap to Revenue|Perrigo (PRGO) - Price-to-Revenue Ratio|ALVO (Alvotech S.A.) - Price-to-Revenue Ratio|Market Cap to Revenue LQDA|P/S Multiple Galapagos Corp|Price-to-Revenue Ratio ANI Pharma (ANIP)|P/S Multiple MannKind Corporation (MNKD)|Price-to-Revenue Ratio Amphastar Pharmaceuticals Inc AMPH|P/S Multiple Pacira PCRX|ARS Pharmaceuticals Inc - P/S Multiple|TBPH - P/S Multiple|AQST (Aquestive Therapeutics) - Market Cap to Revenue|scPharmaceuticals, Inc. (SCPH) - P/S Multiple|Market Cap to Revenue TECX|P/S Multiple Tonix Pharma|Market Cap to Revenue SXTC (SXT Pharmaceuticals)|EPRX: Price-to-Sales Ratio|BioHarvest Sciences - Market Cap to Revenue|EXOZ: Market Cap to Revenue Ratio|ORMP - Price-to-Revenue Ratio|ENTX: Price-to-Revenue Ratio|HYFT: P/S Multiple|Market Cap to Revenue ABVC BioPharma Inc|CPIX (Cumberland Corp) - P/S Multiple|P/S Multiple quantumbiopharma.com|P/S Multiple FGEN|Market Cap to Revenue Telomir Pharmaceuticals, Inc. TELO|P/S Multiple RANI (Rani Therapeutics)|SNYR (Synergy CHC Corp) - Price-to-Sales Ratio|RLYB: Market Cap to Revenue|lexariabioscience.com (LEXX) - Market Cap to Revenue|Pulmatrix Inc (PULM) - Price-to-Revenue Ratio|PTHL: Market Cap to Sales Volume|APM (Aptorum Group Ltd) - P/S Multiple|Lyra Therapeutics Inc (LYRA) - Price-to-Revenue Coefficient|P/S Multiple IBO|Market Cap to Sales Volume TNFA|cbdMD, Inc. - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio PRFX|Altamira Therapeutics Ltd. - P/S Multiple|LIPO: Price-to-Revenue Ratio|OPTN: P/S Multiple|Price-to-Sales Ratio PIRS (Pieris Pharmaceuticals)|PROC (Procaps) - P/S Multiple|PTPI (Petros Pharmaceuticals Inc) - Market Cap to Sales Volume|P/S Multiple QLI|SLRN - Price to Sales|P/S Multiple TFFP (TFF Pharmaceuticals, Inc)